follows. Unit : Million baht 2018 2017 Cost of medical treatment 635.49 618.16 Cost of selling medical equipment 114.92 60.65 Administrative expenses 112.70 109.64 Finance costs 13.88 22.86 Finance costs

Administrative expenses 345.64 125.89 Cost of amortization 2.58 2.41 Finance costs 45.86 6.53 Finance costs (net) 37.80 3.10 Proportion of cost of medical treatment / revenue of medical treatment 73.97 67.76

equipment 614.09 407.46 Administrative expenses 516.93 486.11 Loss from Impairment of Investment 248.04 56.89 Finance costs 46.17 61.87 Finance costs (net) 32.25 46.22 Proportion of cost of medical treatment

70.33 109.73 Total Revenues 9,131.98 9,444.46 Selling and Administrative Expense 692.28 605.22 Finance Costs 85.90 78.95 Net Profit (loss) 23.72 417.46 Net Profit (loss) attributable to the parent company

ter 2 Quar ter 1-2 Profit Attributable to Owner of the Parent - Previously Reported 2,200.99 3,559.43 Finance Costs (Increase) / Decrease (114.61) (297.48) Share of Profit of Associates and Joint

venture 157.5 545.2 -387.7 -71.1 Share of profit (loss) from investment in associates and joint venture 49.7 31.7 18.0 56.6 EBIT 207.2 577.0 -369.8 -64.1 Interest income 29.7 4.3 25.4 587.6 Finance cost

% Share of profit (loss) from investment in associates and joint venture 174.1 235.4 -61.3 -26.0% EBIT 916.1 1,991.4 -1,075.3 -54.0% Finance income 81.3 11.2 70.2 629.3% Finance cost -308.5 -325.6 17.1 -5.3

the third quarter of 2018, details of share of profit from investment in associates compared to the third quarter of 2017 are as follows: Name of the Company Quarter 3 rd /2019 Quarter 3 rd /2018 LH

737.23 576.73 Cost 551.44 458.12 Gross profit 185.79 118.61 Gross profit margin 25.20% 20.57% 6. In the second quarter of 2017, details of share of profit from investment in associates compared to the

Expenses 659.4 75.1 1,595.3 64.5 935.9 141.9 Profit before share of loss from investments in joint ventures, finance cost and income tax expenses 218.6 24.9 878.4 35.5 659.8 301.9 Share of loss from